TY - JOUR
T1 - Implementation of Preexposure Prophylaxis for Human Immunodeficiency Virus Prevention among Men Who Have Sex with Men at a New England Sexually Transmitted Diseases Clinic
AU - Chan, Philip A.
AU - Glynn, Tiffany R.
AU - Oldenburg, Catherine E.
AU - Montgomery, Madeline C.
AU - Robinette, Ashley E.
AU - Almonte, Alexi
AU - Raifman, Julia
AU - Mena, Leandro
AU - Patel, Rupa
AU - Mayer, Kenneth H.
AU - Beauchamps, Laura S.
AU - Nunn, Amy S.
N1 - Funding Information:
Sources of The study was supported by a research grant from Gilead Sciences, Inc. PAC is supported by the National Institute of Allergy and Infectious Diseases (1K23AI096923). CEO is supported by the National Institute of Drug Abuse (T32DA013911) and the National Institute of Mental Health (R25MH083620). JR is supported by the National Institute of Allergy and Infectious Diseases (T32AI102623) and the National Institute of Mental Health (R25MH083620). RP is supported by the National Center for Advancing Translational Sciences (KL2TR000450). Additional support was provided by the Lifespan/ Tufts/Brown Center for AIDS Research (P30AI042853).
Publisher Copyright:
Copyright © 2016 American Sexually Transmitted Diseases Association All rights reserved.
PY - 2016/11/1
Y1 - 2016/11/1
N2 - Background Preexposure prophylaxis (PrEP) is efficacious in preventing human immunodeficiency virus (HIV) among men who have sex with men (MSM). We assessed PrEP uptake among MSM presenting for services at a sexually transmitted diseases (STD) clinic. Methods Men who have sex with men presenting to the Rhode Island STD Clinic between October 2013 and November 2014 were educated about, and offered, PrEP. We categorized PrEP engagement using an implementation cascade to describe gaps in uptake which described MSM who: (1) were educated about PrEP, (2) indicated interest, (3) successfully received follow-up contact, (4) scheduled an appointment, (5) attended an appointment, and (6) initiated PrEP (ie, received a prescription). Bivariate and multivariable logistic regression models were used to examine predictors of PrEP initiation. Results A total of 234 MSM were educated about PrEP; of these, 56% expressed interest. Common reasons for lack of interest were low HIV risk perception (37%), wanting more time to consider (10%), concern about side effects (7%), and financial barriers (3%). Among those interested, 53% followed up. Of those, 51% scheduled an appointment. The most common reason patients did not schedule an appointment was low HIV risk perception (38%). Seventy-seven percent of those with an appointment attended the appointment; of those, 93% initiated PrEP. Patients with higher HIV-risk perception (adjusted odds ratios, 2.17; 95% confidence interval, 1.29-3.64) and a history of sex with an HIV-positive partner (adjusted odds ratios, 7.08; 95% confidence interval, 2.35-21.34) had significantly higher odds of initiating PrEP. Conclusions Low HIV-risk perception was the most significant barrier to PrEP uptake among MSM attending a public STD clinic.
AB - Background Preexposure prophylaxis (PrEP) is efficacious in preventing human immunodeficiency virus (HIV) among men who have sex with men (MSM). We assessed PrEP uptake among MSM presenting for services at a sexually transmitted diseases (STD) clinic. Methods Men who have sex with men presenting to the Rhode Island STD Clinic between October 2013 and November 2014 were educated about, and offered, PrEP. We categorized PrEP engagement using an implementation cascade to describe gaps in uptake which described MSM who: (1) were educated about PrEP, (2) indicated interest, (3) successfully received follow-up contact, (4) scheduled an appointment, (5) attended an appointment, and (6) initiated PrEP (ie, received a prescription). Bivariate and multivariable logistic regression models were used to examine predictors of PrEP initiation. Results A total of 234 MSM were educated about PrEP; of these, 56% expressed interest. Common reasons for lack of interest were low HIV risk perception (37%), wanting more time to consider (10%), concern about side effects (7%), and financial barriers (3%). Among those interested, 53% followed up. Of those, 51% scheduled an appointment. The most common reason patients did not schedule an appointment was low HIV risk perception (38%). Seventy-seven percent of those with an appointment attended the appointment; of those, 93% initiated PrEP. Patients with higher HIV-risk perception (adjusted odds ratios, 2.17; 95% confidence interval, 1.29-3.64) and a history of sex with an HIV-positive partner (adjusted odds ratios, 7.08; 95% confidence interval, 2.35-21.34) had significantly higher odds of initiating PrEP. Conclusions Low HIV-risk perception was the most significant barrier to PrEP uptake among MSM attending a public STD clinic.
UR - http://www.scopus.com/inward/record.url?scp=84992223479&partnerID=8YFLogxK
U2 - 10.1097/OLQ.0000000000000514
DO - 10.1097/OLQ.0000000000000514
M3 - Article
C2 - 27893604
AN - SCOPUS:84992223479
VL - 43
SP - 717
EP - 723
JO - Sexually Transmitted Diseases
JF - Sexually Transmitted Diseases
SN - 0148-5717
IS - 11
ER -